CAMCI: Advancing the Use of Computerized Screening in Healthcare

CAMCI：推进计算机化筛查在医疗保健领域的应用

• 批准号: 9466563
• 负责人: Amy Eschman
• 金额: $ 83.62万
• 依托单位: PSYCHOLOGY SOFTWARE TOOLS, INC.
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-06-01 至 2020-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9466563
• 关键词: African American; Agreement; Algorithms; Alzheimer' s Disease; Assessment tool; Businesses; Caring; Characteristics; Classification; Clinical; Clinical Research; Clinical Trials; Clinical effectiveness; Cognitive; Collection; Communities; Computers; Consult; Coupled; Current Procedural Terminology Codes; Data Collection; Data Set; Dementia; Detection; Development; Development Plans; Devices; Diagnosis; Disease; Disease Progression; Early Diagnosis; Early Intervention; Effectiveness; Elderly; Evaluation; Failure; Family; Feedback; Funding; Future; Goals; Grouping; Health; Health Personnel; Health Professional; Healthcare; Healthcare Systems; Hispanics; Hospitals; Impaired cognition; Impairment; Individual; Insurance; Intellectual Property; Investments; Lawyers; Legal patent; Life; Market Research; Marketing; Measures; Medical; Medical Device; Memory impairment; Minority; Mission; Neuropsychological Tests; Neuropsychology; Older Population; Outcome; Patients; Physicians; Physicians' Offices; Population; Primary Care Physician; Provider; Psychologist; Psychology; Quality of life; Readability; Recruitment Activity; Reporting; Research; Research Personnel; Retirement; Sampling; Schedule; Secure; Self-Administered; Sensitivity and Specificity; Site; Software Tools; Stream; Symptoms; Testing; Therapeutic Intervention; Time; Training; United States; Universities; Validation; clinical practice; clinically significant; cognitive function; college; commercialization; computerized; computerized tools; cost; design; ethnic minority population; experience; improved; meetings; neurophysiology; older patient; portability; product development; racial and ethnic; research and development; screening; slow potential; tool; usability

Cognitive dysfunction in the elderly population, ranging from simple forgetfulness to a diagnosis of Alzheimer’s disease, can impact one’s quality of life and ability to function in daily activities. It is crucial that decline be detected as early as possible in order to evaluate whether the cause is treatable, and to employ appropriate treatment, if applicable. The majority of older patients rely on their primary care physician for the bulk of their healthcare needs, but there is a lack of sensitive tools available to the physician, and there is a lack of physician’s time to use the tools that are available, leading to a failure to provide therapeutic intervention at the earliest stages of loss to potentially slow the progression of disease. There is a clear need for an easy-to-use and brief assessment tool designed to target early cognitive decline, and a need to introduce the tool to providers who most frequently care for the elderly population: Primary Care Physicians (PCPs). Psychology Software Tools, Inc. (PST) has developed such a tool, the Computer Assessment of Memory and Cognitive Impairment (CAMCI), a computerized screening tool for the detection of early signs of cognitive decline, which has been shown to be more effective in the identification of patients with subtle cognitive loss than the tool most frequently used within the PCP office (i.e., MMSE). With PST’s considerable experience in computerized testing and working with older populations, and in accordance with PST’s company mission to advance the fields of research and assessment, CAMCI would provide an option for PCPs and clinicians to provide therapeutic intervention prior to a diagnosis of dementia. Recent additions to CPT codes permit insurance reimbursement for neuropsychological testing by a computer, including time for the physician's or clinical psychologist's interpretation and reporting. The introduction of this new revenue stream for PCPs and clinicians, coupled with the characteristics of being brief and self-administered make CAMCI an attractive option for improving early intervention, providing an intelligent business solution for healthcare professionals, and a useful and effective tool that allows physicians to better evaluate and serve their patients. The specific aims included in the current project are focused on activities required to successfully move CAMCI to commercialization by extending support for late stage research and product development, including regulatory strategy and intellectual property development, data collection to replicate key studies, product extension through increasing minority representation, and development of a measure of meaningful change. The ultimate goal is to streamline the commercialization of CAMCI, and to provide a useful and effective tool in the detection of cognitive dysfunction to physicians, the providers of the majority of healthcare to the elderly population, to improve efficiency and effectiveness of clinical practice.

老年人的认知功能障碍，从简单的健忘到诊断为 阿尔茨海默病，可以影响一个人的生活质量和日常活动的能力。至关重要 尽可能早地检测到下降，以评估原因是否可以治疗，并采用 适当的治疗，如适用。大多数老年患者依靠他们的初级保健医生， 他们的医疗保健需求的大部分，但缺乏敏感的工具提供给医生， 缺乏医生的时间来使用可用的工具，导致无法提供治疗 在损失的最早阶段进行干预，以潜在地减缓疾病的进展。有明确 需要一个易于使用和简短的评估工具，旨在针对早期认知能力下降，并需要 向最经常照顾老年人口的提供者介绍该工具：初级保健医生 （PCP）。Psychology Software Tools，Inc. (PST)开发了这样一种工具，计算机评估 记忆和认知障碍（CAMCI），用于检测早期体征的计算机化筛查工具 认知能力下降，这已被证明是更有效的识别患者的微妙 比PCP办公室内最常用的工具（即，MMSE）。由于太平洋标准时间相当长， 在计算机化测试和老年人工作的经验，并按照PST的 公司的使命是推进研究和评估领域，CAMCI将提供一个选择， PCP和临床医生在诊断痴呆症之前提供治疗干预。最近新增 CPT代码允许通过计算机进行神经心理测试的保险报销，包括时间 供医生或临床心理学家解释和报告。这项新收入的引入 流的PCP和临床医生，再加上简短和自我管理的特点，使 CAMCI是改善早期干预的有吸引力的选择，为以下方面提供智能业务解决方案： 医疗保健专业人员，以及一个有用和有效的工具，使医生能够更好地评估和服务 他们的病人本项目的具体目标侧重于开展必要的活动， 通过扩大对后期研究和产品的支持，成功地将CAMCI推向商业化 发展，包括监管战略和知识产权发展，数据收集， 关键研究，通过增加少数群体代表性扩大产品，并制定措施 有意义的改变。最终目标是简化CAMCI的商业化，并提供一个 有用和有效的工具，在检测认知功能障碍的医生，提供者的大多数 为老年人提供医疗保健服务，以提高临床实践的效率和有效性。